Should You Buy The Dogs Of The FTSE For 2015? Royal Dutch Shell Plc, GlaxoSmithKline plc, Standard Chartered PLC, Direct Line Insurance Group PLC And Admiral Group plc

Royal Dutch Shell Plc (LON:RDSB), GlaxoSmithKline plc (LON:GSK), Standard Chartered PLC (LON:STAN), Direct Line Insurance Group PLC (LON:DLG) and Admiral Group plc (LON:ADM) could all beat the market in 2015.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

This is the second part of my two-part series looking at the 10 FTSE 100 stocks that qualify for a UK version of the popular Dogs of the Dow high-yield investment strategy.

The Dogs strategy involves buying the 10 highest-yielding stocks in the index at the start of the year, and then selling them at the end of the year. In the US, the Dogs strategy has beaten the Dow in two of the last three years.

Here are the final five 2015 Dog stocks from the FTSE 100 (if you missed the first five stocks, you can catch up here):

Company

2015 prospective yield

Royal Dutch Shell (LSE: RDSB)

5.9%

GlaxoSmithKline (LSE: GSK)

5.9%

Standard Chartered (LSE: STAN)

6.0%

Direct Line Insurance Group (LSE: DLG)

7.4%

Admiral Group (LSE: ADM)

6.9%

Shell

No-one quite knows how the oil market will behave next year.

However, Shell should be able to afford to ride out the storm, thanks to its huge scale, large gas business and low debt levels.

Although cash flow could come under pressure next year, the firm’s forecast P/E of 9.8 suggests to me that Shell remains a safe income buy.

GlaxoSmithKline

Allegations of bribery and corruption, patent expiries, and falling profits.

It’s been a poor year for Glaxo, but this has left the UK’s largest pharmaceutical firm trading with a prospective yield of nearly 6% and a planned 82p per share capital return in 2015.

Glaxo remains in my portfolio, and on my buy list.

Standard Chartered

Shares in Asia-focused Standard Chartered have fallen by around 35% this year, amid a constant run of downgraded forecasts.

As a result, the bank’s shares trade on a 2015 forecast P/E of just 8.1, which prices in a lot of bad news, in my view. A prospective yield of around 5.9% should also reward patient investors.

Direct Line

Direct Line makes it into the Dogs of the FTSE thanks to a generous special dividend policy, which gives the firm’s shares a prospective yield of 7.4%, the highest in this group.

The fall in motor insurance premiums does seem to be slowing, so 2015 could be a reasonable year for Direct Line.

Admiral

As with Direct Line, it’s important to remember that these insurers’ generous yields are driven by special dividends, which are currently being paid every year, but may not be in the future.

That aside, Admiral’s 2015 forecast P/E of 14.2 reflects the fact that earnings per share are expected to fall by around 8% next year, raising the risk that dividend growth could also stall.

Roland Head owns shares in Royal Dutch Shell and GlaxoSmithKline. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Emma Raducanu for Vodafone billboard animation at Piccadilly Circus, London
Investing Articles

Is now the time to consider buying Vodafone shares?

Vodafone shares have been on a roll, transforming a £5,000 investment 12 months ago into £8,455 today. But is the…

Read more »

Female Tesco employee holding produce crate
Investing Articles

Is now the time to consider buying Tesco shares?

Tesco shares have been a stellar performer over the last 12 months, but can this momentum continue? Or is it…

Read more »

Finger clicking a button marked 'Buy' on a keyboard
Investing Articles

Is this the perfect time to consider buying Legal & General shares?

Legal & General shares have one of the FTSE 100's biggest forecast dividend yields for 2026. Maybe we should think…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

These are the FTSE 100’s 5 biggest passive-income streams!

These five FTSE 100 firms are expected to pay out £30.5bn in cash dividends in 2026. I'm a huge fan…

Read more »

Investing Articles

Up 50% in a year! Now check out the intriguing BP share price forecast for the next 12 months

The BP share price is up one day, down the next, as geopolitical uncertainty rattles the FTSE 100. Harvey Jones…

Read more »

Investing Articles

Is now the perfect time to buy high-yield FTSE 100 dividend shares? 

Harvey Jones says UK dividend shares have a brilliant track record of delivering income and growth, and he can see…

Read more »

Bronze bull and bear figurines
Investing Articles

At 7,000 points, the S&P 500 looks bloated. How should investors navigate this market?

AI-hype may have ballooned the S&P 500 into the mother of all bubbles – but only time will tell. For…

Read more »

Smart young brown businesswoman working from home on a laptop
Investing Articles

How £100 can start a portfolio of UK stocks

Whether it’s building wealth or earning passive income, UK investors might be surprised at what £100 a month in stocks…

Read more »